Long‐Term Renal Allograft Survival: Have we Made Significant Progress or is it Time to Rethink our Analytic and Therapeutic Strategies?

Impressive renal allograft survival improvement between 1988 and 1995 has been described using projections of half‐lives based on limited actual follow up. We aimed, now with sufficient follow up available to calculate real half‐lives. Real half‐lives calculated from Kaplan‐Meier curves for the over...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of transplantation 2004-08, Vol.4 (8), p.1289-1295
Hauptverfasser: Meier‐Kriesche, Herwig‐Ulf, Schold, Jesse D., Kaplan, Bruce
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1295
container_issue 8
container_start_page 1289
container_title American journal of transplantation
container_volume 4
creator Meier‐Kriesche, Herwig‐Ulf
Schold, Jesse D.
Kaplan, Bruce
description Impressive renal allograft survival improvement between 1988 and 1995 has been described using projections of half‐lives based on limited actual follow up. We aimed, now with sufficient follow up available to calculate real half‐lives. Real half‐lives calculated from Kaplan‐Meier curves for the overall population as well as subsets of repeat transplants and African Americans recipients were examined. Real half‐lives were substantially shorter than projected half‐lives. As a whole, half‐lives have improved by about 2 years between 1988 and 1995 as compared to the earlier projected 6 years of improvement. The improvement seems to be driven primarily by the improvement in graft survival of re‐transplants. First transplants showed a cumulative increase in graft survival of less than 6 months. Projected half‐lives are a risky estimation of long‐term survival especially when based on short actual follow up. First transplant survival has only marginally improved during the early years of post transplant follow up while no significant improvement in long‐term survival could be detected between 1988 and 1995. Redirection of attention from early endpoints towards the process of long‐term graft loss may be necessary to sustain early gains in the long term.
doi_str_mv 10.1111/j.1600-6143.2004.00515.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66733094</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>66733094</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4145-f0ea17685d7aa02cb3333556003106d9e4c3a3ec47a081fb86d6fc9a8a6ee203</originalsourceid><addsrcrecordid>eNqNkU2P0zAQhi0EYj_gL6A5cWuw48RJERKqVsCCikA0d2vqTLou-Si2093e9sqN38gvwaHVcmUuHsvPvCO_L2MgeCJivdomQnE-UyKTScp5lnCeizy5e8TOHx4eP_QyP2MX3m85F0Vapk_ZmchTVRaSn7Ofy6Hf_L7_VZHr4Bv12MKibYeNwybAanR7u8f2NVzjnuCW4DPWBCu76W1jDfYBvrrIkvcwOLAebIDKdgRhiGLhxvbfYRgdLKLuIVgD2NdQ3ZDDHY3TfRUcBtpY8m-fsScNtp6en85LVr1_V11dz5ZfPny8WixnJhNZPms4oShUmdcFIk_NWsbK8_hTKbiq55QZiZJMViAvRbMuVa0aM8cSFVHK5SV7eZTdueHHSD7oznpDbYs9DaPXShVS8nkWwfIIGjd476jRO2c7dActuJ5S0Fs9Gawns_WUgv6bgr6Loy9OO8Z1R_W_wZPtEXhzBG5tS4f_FtaLT1Vs5B8IiZdY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66733094</pqid></control><display><type>article</type><title>Long‐Term Renal Allograft Survival: Have we Made Significant Progress or is it Time to Rethink our Analytic and Therapeutic Strategies?</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Meier‐Kriesche, Herwig‐Ulf ; Schold, Jesse D. ; Kaplan, Bruce</creator><creatorcontrib>Meier‐Kriesche, Herwig‐Ulf ; Schold, Jesse D. ; Kaplan, Bruce</creatorcontrib><description>Impressive renal allograft survival improvement between 1988 and 1995 has been described using projections of half‐lives based on limited actual follow up. We aimed, now with sufficient follow up available to calculate real half‐lives. Real half‐lives calculated from Kaplan‐Meier curves for the overall population as well as subsets of repeat transplants and African Americans recipients were examined. Real half‐lives were substantially shorter than projected half‐lives. As a whole, half‐lives have improved by about 2 years between 1988 and 1995 as compared to the earlier projected 6 years of improvement. The improvement seems to be driven primarily by the improvement in graft survival of re‐transplants. First transplants showed a cumulative increase in graft survival of less than 6 months. Projected half‐lives are a risky estimation of long‐term survival especially when based on short actual follow up. First transplant survival has only marginally improved during the early years of post transplant follow up while no significant improvement in long‐term survival could be detected between 1988 and 1995. Redirection of attention from early endpoints towards the process of long‐term graft loss may be necessary to sustain early gains in the long term.</description><identifier>ISSN: 1600-6135</identifier><identifier>EISSN: 1600-6143</identifier><identifier>DOI: 10.1111/j.1600-6143.2004.00515.x</identifier><identifier>PMID: 15268730</identifier><language>eng</language><publisher>9600 Garsington Road , Oxford , OX4 2DQ , UK: Munksgaard International Publishers</publisher><subject>Aged ; Databases as Topic ; Era effect ; Female ; Graft Rejection ; Graft Survival ; half life ; Humans ; kidney transplantation ; Kidney Transplantation - methods ; Kidney Transplantation - trends ; long term outcomes ; Male ; Middle Aged ; Multivariate Analysis ; projection ; Proportional Hazards Models ; Registries ; Risk ; Survival Rate ; Time Factors ; Transplantation, Homologous - methods ; Treatment Outcome</subject><ispartof>American journal of transplantation, 2004-08, Vol.4 (8), p.1289-1295</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4145-f0ea17685d7aa02cb3333556003106d9e4c3a3ec47a081fb86d6fc9a8a6ee203</citedby><cites>FETCH-LOGICAL-c4145-f0ea17685d7aa02cb3333556003106d9e4c3a3ec47a081fb86d6fc9a8a6ee203</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1600-6143.2004.00515.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1600-6143.2004.00515.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15268730$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Meier‐Kriesche, Herwig‐Ulf</creatorcontrib><creatorcontrib>Schold, Jesse D.</creatorcontrib><creatorcontrib>Kaplan, Bruce</creatorcontrib><title>Long‐Term Renal Allograft Survival: Have we Made Significant Progress or is it Time to Rethink our Analytic and Therapeutic Strategies?</title><title>American journal of transplantation</title><addtitle>Am J Transplant</addtitle><description>Impressive renal allograft survival improvement between 1988 and 1995 has been described using projections of half‐lives based on limited actual follow up. We aimed, now with sufficient follow up available to calculate real half‐lives. Real half‐lives calculated from Kaplan‐Meier curves for the overall population as well as subsets of repeat transplants and African Americans recipients were examined. Real half‐lives were substantially shorter than projected half‐lives. As a whole, half‐lives have improved by about 2 years between 1988 and 1995 as compared to the earlier projected 6 years of improvement. The improvement seems to be driven primarily by the improvement in graft survival of re‐transplants. First transplants showed a cumulative increase in graft survival of less than 6 months. Projected half‐lives are a risky estimation of long‐term survival especially when based on short actual follow up. First transplant survival has only marginally improved during the early years of post transplant follow up while no significant improvement in long‐term survival could be detected between 1988 and 1995. Redirection of attention from early endpoints towards the process of long‐term graft loss may be necessary to sustain early gains in the long term.</description><subject>Aged</subject><subject>Databases as Topic</subject><subject>Era effect</subject><subject>Female</subject><subject>Graft Rejection</subject><subject>Graft Survival</subject><subject>half life</subject><subject>Humans</subject><subject>kidney transplantation</subject><subject>Kidney Transplantation - methods</subject><subject>Kidney Transplantation - trends</subject><subject>long term outcomes</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>projection</subject><subject>Proportional Hazards Models</subject><subject>Registries</subject><subject>Risk</subject><subject>Survival Rate</subject><subject>Time Factors</subject><subject>Transplantation, Homologous - methods</subject><subject>Treatment Outcome</subject><issn>1600-6135</issn><issn>1600-6143</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU2P0zAQhi0EYj_gL6A5cWuw48RJERKqVsCCikA0d2vqTLou-Si2093e9sqN38gvwaHVcmUuHsvPvCO_L2MgeCJivdomQnE-UyKTScp5lnCeizy5e8TOHx4eP_QyP2MX3m85F0Vapk_ZmchTVRaSn7Ofy6Hf_L7_VZHr4Bv12MKibYeNwybAanR7u8f2NVzjnuCW4DPWBCu76W1jDfYBvrrIkvcwOLAebIDKdgRhiGLhxvbfYRgdLKLuIVgD2NdQ3ZDDHY3TfRUcBtpY8m-fsScNtp6en85LVr1_V11dz5ZfPny8WixnJhNZPms4oShUmdcFIk_NWsbK8_hTKbiq55QZiZJMViAvRbMuVa0aM8cSFVHK5SV7eZTdueHHSD7oznpDbYs9DaPXShVS8nkWwfIIGjd476jRO2c7dActuJ5S0Fs9Gawns_WUgv6bgr6Loy9OO8Z1R_W_wZPtEXhzBG5tS4f_FtaLT1Vs5B8IiZdY</recordid><startdate>200408</startdate><enddate>200408</enddate><creator>Meier‐Kriesche, Herwig‐Ulf</creator><creator>Schold, Jesse D.</creator><creator>Kaplan, Bruce</creator><general>Munksgaard International Publishers</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200408</creationdate><title>Long‐Term Renal Allograft Survival: Have we Made Significant Progress or is it Time to Rethink our Analytic and Therapeutic Strategies?</title><author>Meier‐Kriesche, Herwig‐Ulf ; Schold, Jesse D. ; Kaplan, Bruce</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4145-f0ea17685d7aa02cb3333556003106d9e4c3a3ec47a081fb86d6fc9a8a6ee203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Aged</topic><topic>Databases as Topic</topic><topic>Era effect</topic><topic>Female</topic><topic>Graft Rejection</topic><topic>Graft Survival</topic><topic>half life</topic><topic>Humans</topic><topic>kidney transplantation</topic><topic>Kidney Transplantation - methods</topic><topic>Kidney Transplantation - trends</topic><topic>long term outcomes</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>projection</topic><topic>Proportional Hazards Models</topic><topic>Registries</topic><topic>Risk</topic><topic>Survival Rate</topic><topic>Time Factors</topic><topic>Transplantation, Homologous - methods</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Meier‐Kriesche, Herwig‐Ulf</creatorcontrib><creatorcontrib>Schold, Jesse D.</creatorcontrib><creatorcontrib>Kaplan, Bruce</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Meier‐Kriesche, Herwig‐Ulf</au><au>Schold, Jesse D.</au><au>Kaplan, Bruce</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long‐Term Renal Allograft Survival: Have we Made Significant Progress or is it Time to Rethink our Analytic and Therapeutic Strategies?</atitle><jtitle>American journal of transplantation</jtitle><addtitle>Am J Transplant</addtitle><date>2004-08</date><risdate>2004</risdate><volume>4</volume><issue>8</issue><spage>1289</spage><epage>1295</epage><pages>1289-1295</pages><issn>1600-6135</issn><eissn>1600-6143</eissn><abstract>Impressive renal allograft survival improvement between 1988 and 1995 has been described using projections of half‐lives based on limited actual follow up. We aimed, now with sufficient follow up available to calculate real half‐lives. Real half‐lives calculated from Kaplan‐Meier curves for the overall population as well as subsets of repeat transplants and African Americans recipients were examined. Real half‐lives were substantially shorter than projected half‐lives. As a whole, half‐lives have improved by about 2 years between 1988 and 1995 as compared to the earlier projected 6 years of improvement. The improvement seems to be driven primarily by the improvement in graft survival of re‐transplants. First transplants showed a cumulative increase in graft survival of less than 6 months. Projected half‐lives are a risky estimation of long‐term survival especially when based on short actual follow up. First transplant survival has only marginally improved during the early years of post transplant follow up while no significant improvement in long‐term survival could be detected between 1988 and 1995. Redirection of attention from early endpoints towards the process of long‐term graft loss may be necessary to sustain early gains in the long term.</abstract><cop>9600 Garsington Road , Oxford , OX4 2DQ , UK</cop><pub>Munksgaard International Publishers</pub><pmid>15268730</pmid><doi>10.1111/j.1600-6143.2004.00515.x</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1600-6135
ispartof American journal of transplantation, 2004-08, Vol.4 (8), p.1289-1295
issn 1600-6135
1600-6143
language eng
recordid cdi_proquest_miscellaneous_66733094
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Aged
Databases as Topic
Era effect
Female
Graft Rejection
Graft Survival
half life
Humans
kidney transplantation
Kidney Transplantation - methods
Kidney Transplantation - trends
long term outcomes
Male
Middle Aged
Multivariate Analysis
projection
Proportional Hazards Models
Registries
Risk
Survival Rate
Time Factors
Transplantation, Homologous - methods
Treatment Outcome
title Long‐Term Renal Allograft Survival: Have we Made Significant Progress or is it Time to Rethink our Analytic and Therapeutic Strategies?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T19%3A24%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long%E2%80%90Term%20Renal%20Allograft%20Survival:%20Have%20we%20Made%20Significant%20Progress%20or%20is%20it%20Time%20to%20Rethink%20our%20Analytic%20and%20Therapeutic%20Strategies?&rft.jtitle=American%20journal%20of%20transplantation&rft.au=Meier%E2%80%90Kriesche,%20Herwig%E2%80%90Ulf&rft.date=2004-08&rft.volume=4&rft.issue=8&rft.spage=1289&rft.epage=1295&rft.pages=1289-1295&rft.issn=1600-6135&rft.eissn=1600-6143&rft_id=info:doi/10.1111/j.1600-6143.2004.00515.x&rft_dat=%3Cproquest_cross%3E66733094%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66733094&rft_id=info:pmid/15268730&rfr_iscdi=true